期刊文献+

环氧化酶-2在鼻咽癌中的表达及其临床意义 被引量:10

Expression of cyclooxygenase-2 in nasopharyngeal carcinoma and its significance
下载PDF
导出
摘要 目的 探讨环氧化酶 2 (COX 2 )在鼻咽癌中的表达情况及其与淋巴结转移的关系和可能机制。方法 应用免疫组织化学方法 (SABC法 ) ,检测 62例鼻咽癌病人 (其中颈部淋巴结转移者 18例 )中COX 2、VEGF的表达和微血管密度 (MVD)。结果 COX 2在鼻咽癌中有高度表达 ,其表达阳性率为 77.42 % ,且与鼻咽癌中VEGF表达、微血管密度和颈淋巴结转移密切相关 (P <0 .0 1)。结论 COX 2的高度表达在鼻咽癌的发生、发展及淋巴结转移中起重要作用 ,且这种作用可能通过上调VEGF的表达来实现的。 Objective To investigate the relationship of cyclooxygenase-2 (COX-2) expression with lymph node metastasis in nasopharyngeal carcinoma and the possible mechanisms. Methods Levels of COX-2, vascular endothelial growth factor (VEGF), and microvessel density (MVD) in 62 patients with nasopharyngeal carcinoma (18 patients with lymph node metastasis) were measured by immunohistochemistry (SABC method). Results The positive rate of COX-2 in nasopharyngeal carcinoma was 77.42%. COX-2 expression was closely associated with VEGF expression, MVD, and lymph node metastasis of nasopharyngeal carcinoma (P<0.01). Conclusion The overexpression of COX-2 may play a crucial role in the carcinogenesis and development of nasopharyngeal carcinoma and lymph node metastasis in patients with nasopharyngeal carcinoma by means of up-regulating the expression of VEGF.
出处 《局解手术学杂志》 2004年第3期152-154,共3页 Journal of Regional Anatomy and Operative Surgery
关键词 环氧化酶-2 鼻咽癌 COX-2 基因表达 淋巴结转移 nasopharyngeal carcinoma cyclooxygenase-2 VEGF
  • 相关文献

参考文献10

  • 1Liu XH,Kirschenbaum A,Yao S,et al.Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line[J].Clin E xp Metastasis,1999,
  • 2Lanza-Jacoby S,Miller S,Flynn J,et al .The cyclooxygenase-2 inhibitor,celecoxib,prevents the development of mammary tumors in HER-2/neu mice [ J ].Cancer Epidemiol Biomarkers Prey,2003,12(12):1486-1491.
  • 3Dannenberg AJ,Altorki NK,Boyle JO,et al.Cyclo-oxygenase 2:a pharmacological target for the prevention of cancer [ J ].Lancet Oncol,2001,2(9):544-551.
  • 4Masferrer JL,Leahy KM,Koki AT,et al.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors [ J ].Cancer Res,2000,60(5):1306-1311.
  • 5Weidner N.Intratumor microvessel density as a prognostic factor in cancer[J].Am J Pathol,1995,147(1):9-19.
  • 6Ow K,Delprado W,Fisher R,et al.Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer[ J].J Pathol,2000,191(1):39-47.
  • 7de Vries C,Escobedo JA,Ueno H,et al.The fms-like tyrosine kinase,a receptor for vascular endothelial growth factor[ J].Science 1992,255(5047):989-991.
  • 8Kim KJ,Li B,Winer J,et al.Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo[J].Nature,1993,362(6423):841-844.
  • 9Tille JC,Wang X,Lipson KE,et al.Vascular endothelial growth factor(VEGF) receptor-2 signaling mediates VEGF-C ( deltaNdeltaC)-and VEGF-A-induced angiogenesis in vitro [ J ].Exp Cell Res,2003,285(2):286-298.
  • 10Kraft A,Weindel K,Ochs A,et al.Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[J].Cancer,1999,85(1):178-187.

同被引文献109

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部